Jun Minakuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jun Minakuchi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Manabu Tashiro
Department of Kidney Disease, Kawashima Hospital, Tokushima, Japan
2 shared publications - Tomoko Inoue
Department of Nephrology, Kawashima Hospital, Tokushima, Japan, Japan
2 shared publications - Daisuke Hara
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
1 shared publication - Hiroyuki Michiwaki
Department of Clinical Engineering, Kawashima Hospital, 6-1 Kitasakoiciban-Cho, Tokushima-City 770-0011, Japan
1 shared publication - Hiroyuki Michiwaki
Department of Clinical Engineering, Kawashima Hospital, Tokushima, Japan, Japan
1 shared publication - Hisato Shima
Department of Nephrology and Hypertension, Kamei Hospital
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by MDPI AG in Preprints.org
Controlled Hypoalbuminemia Due to High Albumin Leakage Is Associated with Lower Mortality in Old-Old Patients with Mild Weight Loss and/or Inflammation
Controlled hypoalbuminemia due to high albumin leakage (Alb-L) improves mortality in dialysis patients with mild weight loss and/or inflammation. However, no study has investigated whether it reduces mortality in old-old patients who tend to have progressively worsening hypoalbuminemia, weight loss, and inflammation over time. To address this question, this study retrospectively analyzed 227 dialysis patients aged ≥75 years who were classified into a high Alb-L group (≥3 g/session, n = 93) and a low Alb-L group (2, high-sensitivity C-reactive protein (hs-CRP) level ≥0.3 mg/dL, and a group with BMI 2 and/or hs-CRP level ≥0.3 mg/dL were associated with lower mortality rates in high Alb-L than in low Alb-L, while no associations were observed for BMI 2, hs-CRP level 2 and hs-CRP <0.3 mg/dL. Although low Alb-L was associated with reduced S-Alb and BMI, and elevated serum creatinine (S-Cr) after 3 years, high Alb-L were associated with increased BMI, decreased S-Cr, and the prevention of reduced S-Alb level. Furthermore, in patients without inflammation, either high or low Alb-L was associated with elevated hs-CRP level after 3 years. In contrast, controlled hypoalbuminemia due to high Alb-L was associated with decreased hs-CRP level in patients with mild inflammation, but low Alb-L was not. Controlled hypoalbuminemia due to high Alb-L was associated with lower mortality relative to low Alb-L in exploratory analyses of patients aged ≥75 years with mild weight loss and/or inflammation.
- 9 November 2026
- Published by MDPI AG in Preprints.org
Open AccessControlled Hypoalbuminemia Due to High Albumin Leakage Is Associated with Lower Mortality in Old-Old Patients with Mild Weight Loss and/or Inflammation
Controlled hypoalbuminemia due to high albumin leakage (Alb-L) improves mortality in dialysis patients with mild weight loss and/or inflammation. However, no study has investigated whether it reduces mortality in old-old patients who tend to have progressively worsening hypoalbuminemia, weight loss, and inflammation over time. To address this question, this study retrospectively analyzed 227 dialysis patients aged ≥75 years who were classified into a high Alb-L group (≥3 g/session, n = 93) and a low Alb-L group (2, high-sensitivity C-reactive protein (hs-CRP) level ≥0.3 mg/dL, and a group with BMI 2 and/or hs-CRP level ≥0.3 mg/dL were associated with lower mortality rates in high Alb-L than in low Alb-L, while no associations were observed for BMI 2, hs-CRP level 2 and hs-CRP <0.3 mg/dL. Although low Alb-L was associated with reduced S-Alb and BMI, and elevated serum creatinine (S-Cr) after 3 years, high Alb-L were associated with increased BMI, decreased S-Cr, and the prevention of reduced S-Alb level. Furthermore, in patients without inflammation, either high or low Alb-L was associated with elevated hs-CRP level after 3 years. In contrast, controlled hypoalbuminemia due to high Alb-L was associated with decreased hs-CRP level in patients with mild inflammation, but low Alb-L was not. Controlled hypoalbuminemia due to high Alb-L was associated with lower mortality relative to low Alb-L in exploratory analyses of patients aged ≥75 years with mild weight loss and/or inflammation.
- Open Access
- 24 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1865
Impact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration
Background: Online hemodiafiltration (OHDF) has a lower mortality rate than hemodialysis (HD). We aimed to investigate the impact of the albumin leakage on the mortality of patients receiving HD or OHDF. Methods: In this single-center study, consecutive patients receiving renal replacement therapy between January and April 2018 were retrospectively registered. Using (1:1) propensity score matching, 3-year all-cause mortality was compared between patients receiving HD and OHDF, and the impact of albumin leakage on the mortality rate in both groups was investigated. Results: Of the 460 patients, 137 patients receiving HD were matched with an equal number of patients receiving OHDF. OHDF was associated with higher albumin leakage (p < 0.001) and a lower mortality than HD (log-rank test, p < 0.001). Albumin leakage was associated with mortality in patients receiving HD (per 1 g increase, hazard ratio (HR): 0.495, 95% confidence interval (CI): 0.275–0.888) and patients receiving OHDF (per 1 g increase, HR: 0.734, 95% CI: 0.588–0.915). Patients receiving HD, with the highest albumin leakage tertile (>3 g), had a similar mortality rate to patients receiving OHDF, with similar albumin leakage. Conclusions: The negative relationship between albumin leakage and mortality suggests the benefit of removing middle- to -large-molecular-weight substances to improve survival.
- 24 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1865
Open AccessImpact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration
Background: Online hemodiafiltration (OHDF) has a lower mortality rate than hemodialysis (HD). We aimed to investigate the impact of the albumin leakage on the mortality of patients receiving HD or OHDF. Methods: In this single-center study, consecutive patients receiving renal replacement therapy between January and April 2018 were retrospectively registered. Using (1:1) propensity score matching, 3-year all-cause mortality was compared between patients receiving HD and OHDF, and the impact of albumin leakage on the mortality rate in both groups was investigated. Results: Of the 460 patients, 137 patients receiving HD were matched with an equal number of patients receiving OHDF. OHDF was associated with higher albumin leakage (p < 0.001) and a lower mortality than HD (log-rank test, p < 0.001). Albumin leakage was associated with mortality in patients receiving HD (per 1 g increase, hazard ratio (HR): 0.495, 95% confidence interval (CI): 0.275–0.888) and patients receiving OHDF (per 1 g increase, HR: 0.734, 95% CI: 0.588–0.915). Patients receiving HD, with the highest albumin leakage tertile (>3 g), had a similar mortality rate to patients receiving OHDF, with similar albumin leakage. Conclusions: The negative relationship between albumin leakage and mortality suggests the benefit of removing middle- to -large-molecular-weight substances to improve survival.